2022 Rx: Your new, post-pandemic prescription for success

By Dave Schweppe, Chief Analytics Officer, MedeAnalytics

Despite the common use of the term “post-COVID,” most leaders across the healthcare industry have come to terms with the fact that COVID-19 is not going away. Though we will not be in a pandemic state forever, many of the resulting changes will continue to pervade and impact the way care is developed, delivered, utilized and managed.

We will keep seeing more….

1. Immunization against coronaviruses

We are likely to see yearly COVID shots become the norm, similar to our annual influenza shots.

2. Shifts in how care is accessed

Even after a return to face-to-face care, virtual options have remained popular and necessary. This trend has driven new partnerships and technologies throughout the industry.

3. Focus on behavioral health

The isolation, trauma and stress that accompanied late 2019 to the present day will have a decades-long effect on mental health. Accessible services are both important and imperative.

4. Evolution in the model for clinical quality measurement and trends

2020 had a drastic effect on basic metrics, outcomes and benchmarks, and organizations will need to determine how to use, contextualize and compare those numbers—or whether to ignore them altogether.

5. Urgent prioritization of social drivers of health

Payers and providers alike are finally tuning in to the importance of social and environmental factors. Zip code just may be the best predictor and descriptor of a patient’s health status right now, but that does not have to—and shouldn’t—be the case forever.

6. Technology as triage

Wearables like Apple Watches are measuring and reporting oxygen levels. Diabetes monitors are automatically triggering alerts to family members or clinicians when blood sugar levels dip too low. AI algorithms are evaluating photos of moles and reading breast cancer screenings. These are just a few examples of the vast ways technology is increasingly transforming how we triage patients and get them the right care. 

We need to start engaging in a new Rx for success

So, how do we grow from this? How do we create and implement an approach to care that considers all these changes and needs? It won’t be perfect immediately (or ever), but the process will teach us how to grow and improve. Now is not the time to wait for an answer; it is the time to recover and rebuild by innovating and iterating

Healthcare organizations must invest in and rely on flexible, adaptable data analytics to understand the landscape, respond efficiently, and make the best decisions.

I’ll show you an example to demonstrate:

As I noted above, the pandemic spurred a heightened focus on accessible, affordable behavioral care. At the start of 2020, 95% of behavioral care was delivered face-to-face—but by April of the same year, only 5% was delivered face-to-face. This means almost everyone pivoted to virtual platforms.

By digging into virtual behavioral care data analytics, payers and providers found that clinicians could still effectively use mental health diagnostic tools, and patients were consistently reporting high satisfaction. This is encouraging news because we saw a high volume of virtual visits for behavioral needs into late 2021. Employers, clinicians, health plans and communities can feel confident that remote patients are getting top-of-the-line support.

We can use data to open doors

Milton Berle once said, “if opportunity doesn’t knock, build a door.” I would add, “then use data analytics to open that door and guide the path forward!” That would make a fantastic motto for post-pandemic restoration and rejuvenation across the healthcare industry.

If you’re ready to start using data to open doors, get in touch with our experts here at MedeAnalytics. We’re excited to hear where you’re headed and explore how our tools can help.

David Schweppe

David joined MedeAnalytics in October 2021, bringing more than 30 years of leadership experience in healthcare data, analytics and reporting. He is passionate about finding innovative business and technical solutions that can provide actionable insights to enhance the quality, affordability and value of patient care. In his role, David provides key leadership to the company’s market, product and technology strategies. Additionally, he helps customers identify and implement best in class analytical strategies and solutions to realize the value of informed data-driven decision making.

Get our take on industry trends

How to help employer groups plan in a time of uncertainty

June 15, 2020

Employers and their sponsored health plans are thinking about next year’s benefit designs with a significant challenge not seen before: the effect of the coronavirus pandemic. There are important considerations to take into account before making any decisions about new or existing coverage. Becky Niehus, a director of Product Consulting at MedeAnalytics, explores these new issues and what employers can do to ensure employees are “covered.”

Read on...

Healthcare’s return to “normal” after COVID-19: Is it possible?

June 9, 2020

As providers determine how to get patients to return to facilities for routine disease management and preventive screenings, opportunities are ripe for the application of analytics to triage at the right time to the right setting. Data related to COVID-19 will continue to flow rapidly, but there are possibly more questions than answers now about a return to “normal.”

Read on...

Avoid COVID-19 modeling pitfalls by eliminating bias, using good data

June 2, 2020

COVID-19 models are being used every day to predict the course and short- and long-term impacts of the pandemic. And we’ll be using these COVID-19 models for months to come.

Read on...

Population Health Amid the Coronavirus Outbreak

May 19, 2020

In speaking with many colleagues throughout the provider and payer healthcare community, I’ve found an overwhelming sense of helplessness to the outbreak’s onslaught. This is exacerbated by the constant evolution of reported underlying medical conditions that indicate a higher risk of hospitalization or mortality for a coronavirus patient.

Read on...